These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 15775701)
1. Patients undergoing treatment for pancreatic adenocarcinoma can mount an effective immune response to vaccinations. Tseng JF; Willett CG; Fernandez-del Castillo C; Ryan DP; Clark JW; Zhu AX; Rattner DW; Winkelmann JL; Warshaw AL Pancreatology; 2005; 5(1):67-74. PubMed ID: 15775701 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants. Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D; Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207 [TBL] [Abstract][Full Text] [Related]
3. 13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety. Martinón-Torres F; Gimenez-Sanchez F; Gurtman A; Bernaola E; Diez-Domingo J; Carmona A; Sidhu M; Sarkozy DA; Gruber WC; Emini EA; Scott DA; Pediatr Infect Dis J; 2012 Apr; 31(4):392-9. PubMed ID: 22301472 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine. Pichichero ME; Bernstein H; Blatter MM; Schuerman L; Cheuvart B; Holmes SJ; J Pediatr; 2007 Jul; 151(1):43-9, 49.e1-2. PubMed ID: 17586189 [TBL] [Abstract][Full Text] [Related]
5. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model. Mawas F; Newman G; Burns S; Corbel MJ J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004 [TBL] [Abstract][Full Text] [Related]
6. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Patel SR; Ortín M; Cohen BJ; Borrow R; Irving D; Sheldon J; Heath PT Clin Infect Dis; 2007 Mar; 44(5):625-34. PubMed ID: 17278051 [TBL] [Abstract][Full Text] [Related]
7. A novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups C and Y-tetanus-toxoid conjugate vaccine is immunogenic and induces immune memory when co-administered with DTPa-HBV-IPV and conjugate pneumococcal vaccines in infants. Nolan T; Lambert S; Roberton D; Marshall H; Richmond P; Streeton C; Poolman J; Boutriau D Vaccine; 2007 Dec; 25(51):8487-99. PubMed ID: 17996996 [TBL] [Abstract][Full Text] [Related]
8. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? Scheifele D; Barreto L; Meekison W; Guasparini R; Friesen B CMAJ; 1993 Oct; 149(8):1105-12. PubMed ID: 8221449 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age. Tejedor JC; Moro M; Merino JM; Gómez-Campderá JA; García-del-Rio M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Ruiz-Contreras J; Martin-Ancel A; Roca J; Boceta R; García-Corbeira P; Maechler G; Boutriau D; Pediatr Infect Dis J; 2008 Jul; 27(7):579-88. PubMed ID: 18536619 [TBL] [Abstract][Full Text] [Related]
10. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT). Chan CY; Molrine DC; Antin JH; Wheeler C; Guinan EC; Weinstein HJ; Phillips NR; McGarigle C; Harvey S; Schnipper C; Ambrosino DM Bone Marrow Transplant; 1997 Jul; 20(1):33-8. PubMed ID: 9232253 [TBL] [Abstract][Full Text] [Related]
11. Dose response of CRM197 and tetanus toxoid-conjugated Haemophilus influenzae type b vaccines. Huebner RE; Nicol M; Mothupi R; Käyhty H; Mbelle N; Khomo E; Klugman KP Vaccine; 2004 Dec; 23(6):802-6. PubMed ID: 15542205 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine. Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290 [TBL] [Abstract][Full Text] [Related]
14. Antibody response to polysaccharide conjugate vaccines after nonmyeloablative allogeneic stem cell transplantation. Meerveld-Eggink A; van der Velden AM; Ossenkoppele GJ; van de Loosdrecht AA; Biesma DH; Rijkers GT Biol Blood Marrow Transplant; 2009 Dec; 15(12):1523-30. PubMed ID: 19896075 [TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452 [TBL] [Abstract][Full Text] [Related]
16. Comparison of multiple immunization schedules for Haemophilus influenzae type b-conjugate and tetanus toxoid vaccines following bone marrow transplantation. Vance E; George S; Guinan EC; Wheeler C; Antin JH; Ambrosino DM; Molrine DC Bone Marrow Transplant; 1998 Oct; 22(8):735-41. PubMed ID: 9827969 [TBL] [Abstract][Full Text] [Related]
17. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736 [TBL] [Abstract][Full Text] [Related]
18. Vaccination with polysaccharide-conjugate-vaccines in adult patients with specific antibody deficiency. Shrimpton A; Duddridge M; Ziegler-Heitbrock L Vaccine; 2006 Apr; 24(17):3574-80. PubMed ID: 16507328 [TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation. Molrine DC; Guinan EC; Antin JH; Wheeler C; Parsons SK; Weinstein HJ; McGarigle C; Blanding P; Phillips NR; Ciamarra A; George S; Ambrosino DM Bone Marrow Transplant; 1996 Jun; 17(6):1149-55. PubMed ID: 8807128 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in healthy infants and toddlers given with routine pediatric vaccinations in Canada. Vanderkooi OG; Scheifele DW; Girgenti D; Halperin SA; Patterson SD; Gruber WC; Emini EA; Scott DA; Kellner JD; Pediatr Infect Dis J; 2012 Jan; 31(1):72-7. PubMed ID: 21960186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]